Gastrointestinal - Autism Research Institute https://autism.org/category/gastrointestinal/ Advancing Autism Research and Education Sun, 28 Apr 2024 23:01:54 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.3 The Gut, Autism, and Mental Health https://autism.org/gut-autism/ Tue, 05 Mar 2024 14:39:01 +0000 https://last-drum.flywheelsites.com/?p=16995 Learn about the relationship between the gut-brain axis, mental health, and autism. The speaker: Calliope Holingue, MPH, PhD is a research faculty member at the Center for Autism and Related Disorders at Kennedy Krieger Institute. A psychiatric epidemiologist by training, she also has a joint academic appointment as

The post The Gut, Autism, and Mental Health appeared first on Autism Research Institute.

]]>

Learn about the relationship between the gut-brain axis, mental health, and autism.

The speaker:

Calliope Holingue, MPH, PhD is a research faculty member at the Center for Autism and Related Disorders at Kennedy Krieger Institute. A psychiatric epidemiologist by training, she also has a joint academic appointment as an assistant professor from the Department of Mental Health at Johns Hopkins Bloomberg School of Public Health.

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

  • autism comorbidities

Co-Occurring Conditions and Autism

January 10th, 2022|News, Uncategorized|

Research suggests that individuals with autism experience some conditions―including underlying medical issues, neurodevelopmental differences, and mental health issues―more frequently than the general population. Learning about these potential medical needs can help you

The post The Gut, Autism, and Mental Health appeared first on Autism Research Institute.

]]>
Research Updates: Nutrition and Autism 2023 https://autism.org/research-updates-nutrition-and-autism-2023/ Tue, 17 Oct 2023 16:00:16 +0000 https://last-drum.flywheelsites.com/?p=16041 Kelly Barnhill, MBA, CN, CCN, summarizes emerging research on nutritional approaches and supports for autistic people. She outlines recent investigations on sensory processing and nutrition, dietary changes, and supplementation. The speaker discusses recent systematic reviews, highlighting general consensus and gaps in research. Barnhill describes several ongoing studies and future avenues of

The post Research Updates: Nutrition and Autism 2023 appeared first on Autism Research Institute.

]]>

Kelly Barnhill, MBA, CN, CCN, summarizes emerging research on nutritional approaches and supports for autistic people. She outlines recent investigations on sensory processing and nutrition, dietary changes, and supplementation. The speaker discusses recent systematic reviews, highlighting general consensus and gaps in research. Barnhill describes several ongoing studies and future avenues of investigation before the Q&A session.

In this webinar: 

1:30 – Goals and objectives
2:45 – Critical aspects of current discourse
5:28 – Sensory processing and diet
9:15 – Dietary changes
13:40 – Dietary supplements
14:30 – Systematic reviews and meta-analyses
19:00 – Significant findings from the last year
22:00 – Ongoing and future research
29:03 – Q&A

Current discourse and recent publications

Barnhill outlines presentation goals and objectives and highlights the challenges faced by researchers during the COVID-19 pandemic before diving into research updates (1:30).

She summarizes a study that found that 43 autistic participants had significantly higher histamine and lower thiamine than non-austic controls. The speaker asserts that these findings suggest the need for further research into potential interventions and screenings that target these biomarkers (2:45). A study on the impact of dietary quality on executive function found a correlation between poor dietary quality (high intake of processed carbohydrates) and impaired working memory, executive function, and organizational skills (3:58). Barnhill states that dietary factors impact development trajectories and that improving diet quality can improve educational outcomes (4:25)

Sensory processing and nutrition

The presenter summarizes a study that found autistic children exhibit higher sensory sensitivity to food than their non-autistic peers. Study data also showed lower levels of calcium and vitamin D in the autistic group compared to non-autistic controls. These findings, she continues, reinforce the clinical perspective of food sensitivity in autism, which also emphasizes the impact these sensitivities have on food choices and eating aversions (5:28).

Barnhill cites a study that revealed family units of individuals with food sensitivities also present with different eating profiles (6:00). Another sensory study on BMI found that almost 60% of participants met units for being overweight, and 12% met criteria for thinness or failure to thrive (7:00). These and other studies show autistic children have different eating and feeding styles than non-autistic controls. Barnhill notes that a lot of work is being done to profile how autistic children participate in feeding environments, what their preferences may look like, and appropriate interventions (8:00)

Dietary changes and supplements

Barnhill explains that a growing body of evidence supports dietary changes and vitamin supplementation in autism. A study involving 400 males and 130 females across multiple facilities in the UK tracked nutrition and development over time. Results showed that adopting a ketogenic diet, with professional support, can be a feasible and appropriate intervention for autistic children (9:15). The speaker cites a survey study that revealed no significant differences in routine while starting a ketogenic diet and that it is easy to assist children in starting the diet if necessary (11:00). Barnhill suggests screening for autism in children who present with significant feeding disorders. 

The speaker describes two animal model studies examining the effect of ketogenic diets on mouse behavior. The first study found that mice on ketogenic diets had reduced social and cognitive deficits and repetitive behaviors and an increased abundance of beneficial microbes in the gut, with no adverse side effects reported. A second study found similar results and also indicated that ketogenic diets may restore histone balances in affected mice (12:15). A third mouse model that tested zinc supplementation saw improvements in social interaction and fear but had no effect on social novelty, or the initiation of new circumstances (13:40).

Systematic reviews and meta-analyses

Barnhill presents a review that found low choline and B vitamins and abnormal amino acids in autistic children compared to non-autistic groups (14:50). Another review on probiotic supplementation found evidence that dietary change can increase oxidative stress. The presenter suggests monitoring oxidative stress as a mark of microbiome changes in the future (16:05). Clinical literature reviews assert that autistic individuals are often deficient in vitamins A, C, B6, and B12. Across reviews of gluten-free/casein-free (GF/CF) diets, there is consensus that GF/CF diets are quite feasible and carry few adverse effects (17:03). Barnhill highlights a review of dietary interventions by Amadi et al. as an excellent source for big picture concepts and detailed questions (18:23)

The speaker highlights significant studies from the last year that looked at nutrients/probiotics as anti-inflammatories/modulators (19:00), prenatal diets as a modifier for environmental risk factors for autistic traits (19:50), and assessment and data collection methods across studies (20:35). She explains that to best represent typical dietary intake, three-day real-time collection across weekdays and weekends is needed (21:22)

Ongoing and future research

Barnhill outlines an ongoing study in Florida that explores the impact of eating program interventions (22:25). She also highlights an ongoing longitudinal study assessing the effect of therapeutic GF/CF diet and physiotherapy on the gross motor and cognition of autistic children (23:18). Enrollment is currently open for another exciting study that looks at using folic acid to promote language development (24:01). Finally, the first large study on the impact of mitochondrial function and nutrient intervention is also currently being conducted (25:31). These studies, the speaker asserts, represent a continuous efforts to advance our understanding of autism and identify targeted interventions. 

Barnhill considers future avenues of research and underscores that the most significant barrier to nutritional research is a lack of funding. Contemporary research, she continues, should focus on targeted dietary intakes and anti-inflammatory factors. While GF/CF diets are feasible and effective, she warns against having tunnel vision and reminds viewers that we must always consider more than one avenue (26:30)

Q & A

During the Q&A (29:03), Barnhill discusses picky eating and nutrition in adulthood (31:40), feeding therapy and dietary changes (36:00), paleo diets and multivitamins (38:00), and Celiac and autoimmune diseases in autism (44:50). She also considers good sources for protein (51:45), vitamins (55:15), and multivitamins (57:05).

The speaker:

Kelly Barnhill, MBA, CN, CCN, is the Director of the Nutrition Clinic at The Johnson Center for Child Health and Development. She is a Certified Clinical Nutritionist, with over a decade of experience working with nutrition in children with autism and related disorders. At the Johnson Center she directs a team of dieticians and nutritionists that has served over 3000 children through this practice.

In addition to her clinical practice, Kelly also serves as the Johnson Center Clinical Care Director, overseeing management and implementation of multidisciplinary care across the practices within the organization. In 2008, Kelly accepted the position of Nutrition Coordinator for the Autism Research Institute. In this role, she designs and manages curriculum and training for hundreds of nutrition practitioners each year, as well as providing direct training for thousands of parents. Kelly is a sought-after presenter, speaking at several national and international conferences each year.

Her studies and work at JCCHD are the culmination of many years’ effort and expertise, with the last several years devoted to understanding the biological underpinnings of the disorder we know as autism. Her work has raised awareness of the need for these services for children with autism and related disorders. Kelly is a graduate of The University of Texas at Austin.

Ms. Barnhill also sits on ARI’s Board of Directors and Scientific Advisory Board.

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

  • pans/pots nutrition, autism related disorder

Food and Sleep

March 1st, 2022|Nutrition, Sleep, Ways to Help, Webinar|

Vicki Kobliner, RDN, CD-N, describes nutritional and lifestyle strategies for improving sleep and overall health for autistic people. She discusses circadian rhythm and balancing cortisol and melatonin cycles throughout the day.

The post Research Updates: Nutrition and Autism 2023 appeared first on Autism Research Institute.

]]>
Gastrointestinal Symptoms in Autistic Patients https://autism.org/gi-symptoms-2023/ Tue, 07 Mar 2023 21:53:52 +0000 https://last-drum.flywheelsites.com/?p=15966 In this joint presentation with the World Autism Organization, Frederico Balzola, MD, discusses the intersection of chronic inflammation, gastrointestinal issues, and autism. He considers intestinal permeability and how the microbiome interacts with the central nervous system to affect inflammation in the body. The speaker provides historical context for increased autoimmune and

The post Gastrointestinal Symptoms in Autistic Patients appeared first on Autism Research Institute.

]]>

In this joint presentation with the World Autism Organization, Frederico Balzola, MD, discusses the intersection of chronic inflammation, gastrointestinal issues, and autism. He considers intestinal permeability and how the microbiome interacts with the central nervous system to affect inflammation in the body. The speaker provides historical context for increased autoimmune and inflammatory diseases and highlights the relationship between GI discomfort/pain and behavioral outcomes. Balzola presents a longitudinal study on inflammatory disease pathogenesis and considers what the results mean for autism medical care moving forward. He summarizes the presentation and critical conclusions before the Q&A. 

In this webinar: 

4:00 – Disease origin and the gut
8:00 – Intestinal permeability
11:30 – Zonulin and the tight junction
15:40 – Societal changes and the gut
18:10 – Food systems, diet, hygiene, and antibiotics
25:00 – The microbiome and immune responses
30:15 – Fecal Microbiota Transfer therapy
34:00 – Gut inflammation in autism
37:15 – Behaviors and GI discomfort
42:00 – Longitudinal study on GI inflammation in autism
48:40 – Results and interpretation
50:15 – Environmental risks
54:55 – Summary and conclusion
1:02:11 – Q&A

Intestinal permeability

Balzola describes how the prevalence of autoimmune and inflammatory diseases has drastically increased over the last four decades. He asserts that this observation reaffirms Hippocrates’s theory that all diseases begin in the gut (4:00). Dr. Alessio Fasano said (5:50)

“The bowel is a battlefield where enemy and friends negotiate molecular trafficking leading to either tolerance or immune response. It is the largest interface between our body and the outside world.” 

The speaker discusses the role of intestinal permeability in immune system function and how increased permeability can lead to chronic inflammation and allergies (8:00). Balzola outlines the structure of the gut lining and details the evolutionary history of the Tight Junction – a group of 150 proteins that regulate the paracellular trafficking pathway from the bowel to the blood vessels (11:30). Zonulin, the first component of the Tight Junction, appeared in humans 2 million years ago, and was a critical step in evolution as it allowed for regulation across the intestinal lining. The Zonulin gene is on chromosome 16 and has been implicated in diabetes, obesity, and several autoimmune diseases (13:50)

Societal changes and the gut

Balzola explains how drastic societal and environmental shifts over the last five decades have driven the increase in autoimmune and inflammatory diseases (15:40). He highlights changes in food systems and processing (18:10), diet and meal size (20:55), hygiene and bacterial exposure (22:35), and antibiotic use (24:05). Each of these changes directly impacts the composition of the microbiome and, therefore, the intestinal lining. Contemporary research shows the capacity of the microbiome to influence immune responses and its implication in liver disease, diabetes, autism, Ankylosing Spondylitis, and other inflammatory and autoimmune diseases (28:00). Researchers have also found specific imbalances in the gut that can upregulate Zonulin release, further suggesting that Zonulin is a trigger for inflammation due to its role in intestinal permeability (29:40)

Gastrointestinal issues in autism

The presenter describes differences in microbiota patterns between autistic and non-autistic individuals (30:15). He touches on fecal microbiota transfer therapy (FMT) and its potential as an effective treatment for gut microbial imbalances in autism and other chronic diseases (31:35). Signs of gut inflammation can be challenging to spot in autistic individuals due to differences in communication and sensory perceptions (34:00). Balzola notes that many autistic people have elevated pain thresholds and difficulties with verbal communication, underscoring the association between behavior and pain expression in autism (36:15). Behaviors commonly associated with gastrointestinal (GI) stress in autism include acid reflux, sleep disturbances, and self-injurious behaviors. The speaker describes possible sitting positions that may help to reduce stomach pain, and illustrates differences in school work outcomes according to levels of pain and inflammation (37:15)

Balzola outlines a longitudinal study with 1650 participants, where 339 autistic individuals had significant GI symptoms. He presents study participants’ initial family history and GI symptom information, noting that 46% had macroscopic malabsorption and 88% had behavioral disturbances after GI symptoms developed (42:00). GI lab examinations for the study included esophagus, stomach, colon, and rectum (44:30). One participant with inflammatory bowel disease and chronic excess of eosinophils (white blood cells) was treated with the FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) diet. Results showed a reduction in constipation, abdominal pain, proctalgia, and tenesmus, as well as improvements in hyperactivity, motor skills, and mental attention (48:40). At the one-year follow-up, all symptoms were reduced. Researchers, therefore, conclude that there is a significant association between clinical manifestations and histological alterations, meaning that inflammation induces gastrointestinal diseases and their subsequent behaviors (49:21)

Review and conclusion

The speaker notes that the first 1000 days of life are crucial for clinical inflammatory disease and urges pediatricians to consider this. Environmental risks from pre-conception to postnatal impact inflammatory disease pathogenesis (50:15). He presents a case scenario for cumulative environmental risks, highlighting that the gut microbiome is the result of the sum of every risk and, as such, is very fragile at the beginning (52:30). He summarizes critical points from the presentation and how they translate to changes in perspective and care. Specifically, he urges viewers to consider autism as a multiorgan inflammatory disease and to assume the central nervous system plays a role in intestinal inflammation. He reminds viewers to consider pain thresholds in autistic patients with GI symptoms and to listen to the opinions and experiences of parents to gain a better understanding of autism complexities. Balzola also asserts the need for longitudinal approaches to investigation and medical care to predict and adequately address inflammatory or degenerative diseases (54:55). Most importantly, he continues, it is imperative that evolving information about inflammation in autism is transferred from research to the bedside (1:00:00). He notes Schopenhauer’s three stages of truth before opening to questions (1:01:22)

The speaker:

Federico Balzola, MD,  holds board certification in Gastroenterology and Digestive Endoscopy in 1994 in Italy at the Modena University School of Medicine. He attended medical school in the Turin University School of Medicine, graduated in 1989, where he then completed his gastroenterological residency. He was awarded a training from 1994 to 1995 at Royal Free Hospital in London on measles implication in inflammatory bowel disease as well as from 1995 to 1998 at the Clinical Nutrition Department of the Molinette Hospital of Turin on the small bowel syndrome management. Following his fellowship in Gastroenterology and Clinical Nutrition at the Molinette Hospital in Turin, he has been a consultant in the Gastroenterology and Hepatology Department since 1998 where he oversaw the gastrointestinal clinic and consultation service with a special interest in inflammatory bowel disease and liver/bowel transplantation. He is currently working in the Gastroenterology and Hepatology Intensive Care Unit of Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino. He has numerous scientific publications in international medical journals and he presented in several international meetings his research results. At present, he maintains his practice in gastroenterological fields with a special research interest on autistic patients. He is driving several clinical research in Italy on the identification and treatment of the autistic enteropathy with dietetic and pharmacological approaches. He lives in Turin with his wife, Paola,  and two daughters, Beatrice and Margherita.

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

  • autism comorbidities

Co-Occurring Conditions and Autism

January 10th, 2022|News, Uncategorized|

Research suggests that individuals with autism experience some conditions―including underlying medical issues, neurodevelopmental differences, and mental health issues―more frequently than the general population. Learning about these potential medical needs can help you

The post Gastrointestinal Symptoms in Autistic Patients appeared first on Autism Research Institute.

]]>
Plural ‘Autisms’ and the Promises of Autism Metabolomics https://autism.org/autism-metabolomics/ Tue, 16 Aug 2022 16:03:30 +0000 https://last-drum.flywheelsites.com/?p=15276 The increasing moves towards the pluralisation of autism -- ‘the autisms’ -- and the many routes to a diagnosis of autism. What studying dietary intervention for autism suggests regarding metabolomics and the bigger picture of individualised autism science. Handouts are online HERE This is a joint presentation by ARI

The post Plural ‘Autisms’ and the Promises of Autism Metabolomics appeared first on Autism Research Institute.

]]>

The increasing moves towards the pluralisation of autism — ‘the autisms’ — and the many routes to a diagnosis of autism. What studying dietary intervention for autism suggests regarding metabolomics and the bigger picture of individualised autism science.

Handouts are online HERE

This is a joint presentation by ARI and The World Autism Organisation.

About the speaker:

Paul Whiteley, PhD has been involved in autism research for 25 years under the tutelage of Paul Shattock. He has worked at ESPA Research for 10+ years. Dr. Whitetely’s research interests include (i) the efficacy, safety and science behind dietary intervention for autism, (ii) the role of physical health and wellbeing in autism, and (iii) metabolomics and the potential for biological markers to aid early screening and timely diagnosis of autism and (iv) the pluralisation of autism (‘the autisms’).

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

  • pans/pots nutrition, autism related disorder

Food and Sleep

March 1st, 2022|Nutrition, Sleep, Ways to Help, Webinar|

Vicki Kobliner, RDN, CD-N, describes nutritional and lifestyle strategies for improving sleep and overall health for autistic people. She discusses circadian rhythm and balancing cortisol and melatonin cycles throughout the day.

The post Plural ‘Autisms’ and the Promises of Autism Metabolomics appeared first on Autism Research Institute.

]]>
Clinical Approaches for Gluten-/Casein-Free Diets https://autism.org/gluten-casein-free-diets/ Tue, 25 Jan 2022 19:36:19 +0000 https://last-drum.flywheelsites.com/?p=13883 Kelly Barnhill, MBA, CN, CCN, describes a clinical approach for implementing a gluten-/casein-free diet. About the speaker: Kelly Barnhill, MBA, CN, CCN, is the Director of the Nutrition Clinic at The Johnson Center for Child Health and Development. She is a Certified Clinical Nutritionist,

The post Clinical Approaches for Gluten-/Casein-Free Diets appeared first on Autism Research Institute.

]]>

Kelly Barnhill, MBA, CN, CCN, describes a clinical approach for implementing a gluten-/casein-free diet.

About the speaker:

Kelly Barnhill, MBA, CN, CCN, is the Director of the Nutrition Clinic at The Johnson Center for Child Health and Development. She is a Certified Clinical Nutritionist, with over a decade of experience working with nutrition in children with autism and related disorders. At the Johnson Center she directs a team of dieticians and nutritionists that has served over 3000 children through this practice.

In addition to her clinical practice, Kelly also serves as the Johnson Center Clinical Care Director, overseeing management and implementation of multidisciplinary care across the practices within the organization. In 2008, Kelly accepted the position of Nutrition Coordinator for the Autism Research Institute. In this role, she designs and manages curriculum and training for hundreds of nutrition practitioners each year, as well as providing direct training for thousands of parents. Kelly is a sought-after presenter, speaking at several national and international conferences each year.

Her studies and work at JCCHD are the culmination of many years’ effort and expertise, with the last several years devoted to understanding the biological underpinnings of the disorder we know as autism. Her work has raised awareness of the need for these services for children with autism and related disorders. Kelly is a graduate of The University of Texas at Austin.

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

The post Clinical Approaches for Gluten-/Casein-Free Diets appeared first on Autism Research Institute.

]]>
Overview: Medical Comorbidities and ASD https://autism.org/unrecognized-medical-comorbidities-autism/ Mon, 04 Jan 2021 21:32:30 +0000 https://last-drum.flywheelsites.com/?p=12387 In this brief overview, neurologist Margaret Bauman, MD summarizes symptoms and signs of medical comorbidities that frequently occur, but may go unrecognized, in patients diagnosed with ASD. While the underlying cause of autism spectrum disorder (ASD) is generally unknown, scientists suspect that it is a multifactorial condition affecting multiple body systems. Margaret

The post Overview: Medical Comorbidities and ASD appeared first on Autism Research Institute.

]]>

In this brief overview, neurologist Margaret Bauman, MD summarizes symptoms and signs of medical comorbidities that frequently occur, but may go unrecognized, in patients diagnosed with ASD. While the underlying cause of autism spectrum disorder (ASD) is generally unknown, scientists suspect that it is a multifactorial condition affecting multiple body systems.

Margaret Bauman, MD, discusses medical comorbidities associated with autism and how they affect behavior and quality of life. She outlines some common physical comorbidities, including seizure (1:41), sleep (2:18), hormonal (2:47), urinary (3:00), and gastrointestinal (3:33) disorders, and details how these issues present differently in autistic individuals (1:30). Bauman describes our understanding of challenging behaviors in autism as a form of communication (1:00) and highlights the importance of knowing the signs (6:50).
Individuals with communication difficulties may not be able to describe what hurts or where (4:00). Similarly, sensory issues make it difficult for individuals to determine what is happening in their bodies (5:18). Therefore, Bauman recommends, “… individuals on the spectrum who demonstrate behavioral problems absolutely merit a good physical [and] medical workup (6:41)…. [and] gastrointestinal disorders… need to be one of the first areas of investigation (4:45).” She also suggests that providers who have experience working with individuals with autism be recruited to help create necessary interventions and best outcomes (7:46).

About the speaker:

Margaret Bauman, MD, is a pioneer in the study and treatment of Autism and is highly respected by her fellow clinicians and patients for the level of clinical care she provides and the advances that she has contributed to in the field. Dr. Bauman is a Neurologist and specializes in the diagnosis and treatment of Autism and various neurological disorders in children, adolescents, and adults to include learning and developmental disabilities, seizures, cerebral palsy, and neurogenetic disorders. Dr Bauman is the founding director of the LURIE CENTER, formally called LADDERS (Learning and Developmental Disabilities Evaluation and Rehabilitation Services). Dr. Bauman also established The Autism Research Foundation (TARF), The Autism Research Consortium (TARC), and The Autism Treatment Network (ATN). She has also made significant laboratory research contributions in the neuroanatomical understanding of Autism.

The post Overview: Medical Comorbidities and ASD appeared first on Autism Research Institute.

]]>
Research finds GI issues coincide with challenging behaviors in ASD https://autism.org/gi-issues-challenging-behaviors/ Tue, 14 Apr 2020 06:48:08 +0000 https://last-drum.flywheelsites.com/?p=8818 Dr. Ferguson discusses current research indicating that GI issues coincide with behavior problems in autism. He explains how the autonomic nervous system drives stress response and details its relationship with GI functionality. The speaker describes five studies investigating different aspects of Gi issues, anxiety, stress, and problem behaviors in autism. Ferguson touches on

The post Research finds GI issues coincide with challenging behaviors in ASD appeared first on Autism Research Institute.

]]>

Dr. Ferguson discusses current research indicating that GI issues coincide with behavior problems in autism. He explains how the autonomic nervous system drives stress response and details its relationship with GI functionality. The speaker describes five studies investigating different aspects of Gi issues, anxiety, stress, and problem behaviors in autism. Ferguson touches on pharmacological, vagal, and behavioral treatment strategies before the Q&A. 

Handouts are online HERE

In this webinar: 

2:25 – Prevalence of GI disorders in autism
5:10- Autonomic nervous system and autism
8:12 – Study: GI and stress relationship in autism
10:55 – Study: Psychophysiological associations
13:20 – Study: GI problems, difficult behavior, and internalizing symptoms in autism
16:30 – Results
18:30 – Do GI symptoms predict internalizing or externalizing symptoms?
20:20 – Results
21:44 – Discussion
22:45 – Study: Electrodermal activity and problem behaviors in autism
26:00 – Study premise and outline
27:10 – Analysis of electrodermal activity
29:45 – Relationship between stress response and problem behavior
31:15 – What happens when we treat the stress response?
36:20 – Study: Effects of propranolol on the relationship between GI issues and amygdalar reactivity
39:00 – fMRI results
43:00 – Future directions
46:40 – Take-home messages
47:40 – Acknowledgements and thanks
48:05 – Q & A

Introduction

Ferguson explains that up to 91% of autistic people experience GI difficulties, highlighting the importance of studying GI issues in relation to autism (2:40). Two of the most common GI issues in autism are constipation and irritable bowel syndrome (3:50). Ferguson asserts that altered autonomic nervous system response to stress in autism is linked to these conditions. The speaker outlines the autonomic nervous system (ANS), which controls smooth muscles like those used in breathing and digestion. The ANS is composed of the parasympathetic (PYM) (i.e., rest and digest) and the sympathetic (SYM) (i.e., fight, flight, freeze) branches. Ferguson explains that our bodies strive for a balance between these two systems (7:16). He emphasizes that intestine function is inhibited when the SYM is activated and posits that this could be why individuals with high-stress responses are often constipated (6:40). Ferguson presents numerous studies supporting the assertion that ANS imbalances are associated with GI and behavior difficulties in autism. 

Study 1: GI and stress relationship in autism

This study correlated stress response scores with GI issues in autistic children and adolescents. Baseline cortisol (stress hormone) levels were compared to levels after participants dipped their hands in cold water. They correlated this stress response to GI problems and found that Lower GI issues (e.g., abdominal pain and constipation) positively correlated with cortisol levels (8:12). The study also found a positive correlation between Upper GI issues and inflammation (10:00). Ferguson states that these results suggest that autistic individuals with lower GI issues will likely have high cortisol response to stressors (9:40)

Study 2: Psychophysiological associations

The presenter explains that heart rate variability (HRV) measures the balance between the PYM and SYM. This study correlated HRV scores with Lower GI issues in autistic children and adolescents. Findings showed HRV response to stressors is much higher than average in autistic individuals who have anxiety. The same relationship exists between regressive autism and HRV (12:00). Ferguson therefore asserts that co-occurring anxiety disorders or regressions in autism alter the relationship between the PYM and the GI tract. This transformed relationship, he continues, is likely the cause of many GI issues in autism (13:05)

Study 3: GI problems, problem behavior, and internalizing symptoms in autism

This study aimed to look at the relationship between GI problems, problem behaviors, and internalizing symptoms (e.g., anxiety) in autism. The speaker outlines study methods (14:11) and explains how they correlated scores across two age groups (15:43). Results showed that overall, younger children (ages 2 – 5) have more dietary problems than the older group (ages 6 – 18). However, for both groups, the following data was presented (16:30):

  • 65% experienced constipation
  • 50% experienced stomach aches or pain
  • 29% experienced diarrhea
  • 23% experienced nausea
  • 93% were not taking GI medication
  • 53% were taking medications for other reasons (ADHD, aggression)

The study also assessed whether or not GI symptoms predict internalizing or externalizing symptoms (i.e., anxiety or problem behaviors) (18:44). Researchers found that the younger children acted out more with aggression while the older group had more internalized symptoms. This relationship, he continues, is compounded when an individual is minimally or non-verbal (20:20). Ferguson therefore asserts that GI issues must be addressed in this population, especially in those with communication difficulties (21:44)

Study 4: Electrodermal activity and problem behaviors in autism 

Electrodermal activity, or sweating, is an indicator of stress. This study aimed to see if sweating predicts problem behaviors (22:45). Participants wore sweat monitors, and researchers observed their behaviors in an educational setting (26:00). Results showed (27:10) that there is a rise in skin conductance lasting an average of about 10 minutes leading up to problem behaviors (29:45). This change in conductance is called the anticipatory rise, and it occurred before problem behaviors in 60% of observations (28:30). Ferguson posits that this anticipatory rise is likely the result of discomfort or pain and that it presents an opportunity for caretakers to intervene in the stress response. He outlines two clinical trials using propranolol to treat anxiety (31:15) and constipation (35:10).

Study 5: Effects of propranolol on the relationship between GI issues and amygdalar reactivity

The amygdala is a part of the central nervous system responsible for ANS activation. This study examined the effect of three medications on amygdalar response to emotional faces using fMRI technology (36:20). Participants took three 12-day sessions of different medications: placebo, nadolol, and propranolol. Propranolol is the only one known to penetrate the blood-brain barrier. At the end of each session, participants completed a face-matching task to activate the amygdala (39:00). Researchers correlated GI issues to fMRI results. They found that with the first two medications (placebo and nadolol), there was a statistically significant positive relationship between GI symptoms and amygdalar activity. Contrastingly, after 12 days of propranolol, there was no relationship between GI symptoms and amygdalar activity (40:14). Therefore, Ferguson posits that GI stress is related to the central nervous system. He notes the limitations of this study (42:10)

What’s next?

The presenter describes Transcutaneous Vagus Nerve Stimulation (tVNS) and its potential in treating atypical PYM activation and GI issues in autism. tVNS is a small device that fits in the ear and stimulates the vagus nerve, which is part of the PYM (rest and digest) system. This stimulation helps the body calm down (43:00). Ferguson underscores the difference between blocking SYM activity (i.e., propranolol) and stimulating the PYM (tVNS). He summarizes the presentation and reiterates that GI issues in autism are often associated with an enhanced stress response. This is particularly true for Lower GI issues like constipation. GI symptoms, he continues, have also been associated with internalizing symptoms (i.e., anxiety) and problem behaviors. Stress response activation may often proceed problem behaviors in autism, and much more research is needed on new treatment strategies. Ferguson provides thanks and acknowledgments before the Q&A. 

About the speaker:

University of Missouri Cognitive Neuroscience Laboratory
Assistant Research Professor Adjunct – MU School of Medicine, Department of Radiology

Dr. Ferguson is currently studying the association between immune, endocrine, and psychophysiological markers of stress and gastrointestinal disorders in those with autism spectrum disorder. He is also leading the psychophysiological biomarker assessment for predictors of response to medications, and also the relationship to aberrant behaviors.

 

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

  • serotonin

Gastrointestinal Issues and Autism Spectrum Disorders: Serotonin as a Potential Brain-Gut Link

November 18th, 2014|Gastrointestinal, Gastrointestinal, Health, Immune Issues, Nutrition, Webinar|

Handouts are online at: https://www.ariconference.com/webinars/margolis.pdf Free certificates of participation are available online following successful completion of a brief knowledge quiz at: https://www.classmarker.com/online-test/login/ Kara Gross Margolis is a pediatric gastroenterologist whose clinical subspecialty

The post Research finds GI issues coincide with challenging behaviors in ASD appeared first on Autism Research Institute.

]]>
Holiday SOS: Ask the Nutritionist https://autism.org/holiday-sos-ask-the-nutrtionist/ Tue, 03 Dec 2019 16:53:35 +0000 https://last-drum.flywheelsites.com/?p=9105 Facing airplane food with a picky eater? Visiting grandma's and expecting mountains of sweets? Looking for recipes to support loved ones with food allergies? Join this live Q&A to ask your questions about navigating the nutritional challenges of the holiday season while making the most of it. NOTE: Because this was

The post Holiday SOS: Ask the Nutritionist appeared first on Autism Research Institute.

]]>

Facing airplane food with a picky eater? Visiting grandma’s and expecting mountains of sweets? Looking for recipes to support loved ones with food allergies? Join this live Q&A to ask your questions about navigating the nutritional challenges of the holiday season while making the most of it.

NOTE: Because this was a live Q&A, no knowledge quiz is offered for this particular talk. An email sent to registrants mentioned availability of a knowledge quiz in error.

About the speaker:

Vicki Kobliner MS RDN is a Registered Dietitian/Nutritionist with years of expertise in applying a functional approach to nutrition.  She develops individualized plans for clients which are designed to promote wellness, prevent disease and rebalance underlying nutritional impairments.  A key element of this approach is the optimization of digestive function. Research shows that impairments in this critical nutritional pathway can have a far reaching impact on our brain, immune, detoxification, and other seemingly unrelated systems.  Vicki has extensive experience in using dietary modification, appropriate supplementation and functional lab testing to achieve optimal wellness.
Vicki has  extensive experience using gluten-free, dairy free, low allergen, GFCF, SCD, GAPS, FODMAPS, and other appropriate diets to reduce inflammation and promote healthy digestive function .  She has contributed her expertise to www.gfcfdiet.com and worked with schools to develop a whole foods approach to student meal planning.  She lectures frequently, both locally and nationally, on topics such as autism, special diets for food allergies and intolerances, healthy pregnancy planning and choosing appropriate nutritional supplementation.  She has appeared on television and video. Vicki is a contributing author to the books A Compromised Generation: The Epidemic of Chronic Illness in America’s Children and Essential Remedies for Women’s Health.
  • autism toys

Choosing Toys for a Child with Autism

October 12th, 2020|News|

If you find yourself shopping for a child with autism spectrum disorder, you might wonder about if there are certain toys and gifts are better than others. When choosing a gift for

  • autism, autism holidays, autism holiday planning

Planning for the Holiday Season

November 1st, 2019|News, Parenting|

Autumn and the holiday season brings its joys - and potential challenges - for people with autism. Costumes, candy, disrupted routines, travel, house guests, and new foods and experiences abounding, it can

The post Holiday SOS: Ask the Nutritionist appeared first on Autism Research Institute.

]]>
Interoception Is Impaired in Children, but not Adults, with Autism https://autism.org/interoception-impaired-asd/ Wed, 02 Oct 2019 20:12:49 +0000 https://last-drum.flywheelsites.com/?p=8291 10-2-2019 -- A new study suggests that children, but not adults, with autism spectrum disorders (ASD) have impairments in interoception. Interoception is the ability to sense the internal state of the body—for instance, to accurately identify sensations such as hunger, thirst, pain, and internal temperature. Research shows that accuracy in identifying interoceptive

The post Interoception Is Impaired in Children, but not Adults, with Autism appeared first on Autism Research Institute.

]]>

10-2-2019 — A new study suggests that children, but not adults, with autism spectrum disorders (ASD) have impairments in interoception. Interoception is the ability to sense the internal state of the body—for instance, to accurately identify sensations such as hunger, thirst, pain, and internal temperature.

Research shows that accuracy in identifying interoceptive signals is associated with skill in emotion processing, decision-making, self-regulation, empathy, and theory of mind (the ability to understand that other people have thoughts and feelings). Toby Nicholson and colleagues, the authors of the new study, say, “These wide-ranging associations are in line with theories of embodied cognition that imply cognition is situated in bodily systems, and also point towards a role for interoception in both self and other processing. This has led to a growing interest in the importance of interoception for disorders such as ASD.”

The researchers say, “The idea is that a difficulty interpreting one’s own internal bodily signals early on may interfere with learning about the association between these low-level bodily signals and other higher level feelings and thoughts, restricting the comprehension of oneself, which in turn would have similar effects on understanding other selves.”

To test the interoceptive accuracy of individuals with ASD, the researchers performed two experiments. In the first, involving 21 adults with ASD and 21 neurotypical controls, participants completed two tasks. First, they closed their eyes and silently counted the number of heartbeats they felt during specific time intervals.

Next, they exhaled into a peak flow meter, attempting to reproduce the intensity of each of three exhalations (weak, medium, and firm). The researchers then repeated the heartbeat experiment with a group of 21 children with ASD and 21 neurotypical children.

The researchers found that children with ASD, but not adults, had significant impairments in interoceptive accuracy. This may suggest, they say, that “a ‘decoupling’ of interoception and emotion processing among some children with ASD results in emotions never being fully anchored within the body, making emotions difficult to understand in self and others across the lifespan even once interoception difficulties have resolved.”

Another possibility, they say, is that “local interoceptive signals are not integrated together in a global sense,” affecting not just emotional processing but also the ability of interoceptive processes to bind with other information sources such as memory and perception. Still a third possibility, they suggest, is that interoception and theory of mind are independently impaired, which could explain why emotion-processing impairments persist in ASD even after interoceptive impairments have resolved.

“Interoception is impaired in children, but not adults, with autism spectrum disorder,” Toby Nicholson, David Williams, Katie Carpenter, and Aimilia Kallitsounaki, Journal of Autism and Developmental Disorders, May 24, 2019 (online). Email: David Williams.

This article also appears in Autism Research Review International, Vol. 33, No. 3, 2019

Past issues of Autism Research Review International are available online at 

The post Interoception Is Impaired in Children, but not Adults, with Autism appeared first on Autism Research Institute.

]]>
Helminths as a Cause or a Potential Treatment for Autism? https://autism.org/helminths-as-a-cause-or-a-potential-treatment-for-autism/ Wed, 31 Jul 2019 02:04:03 +0000 https://last-drum.flywheelsites.com/?p=6288 Work in our laboratory has focused on immune function in the gut for more than a decade. Recently, our attention has turned to helminths, intestinal worms, which appear to be extremely important in the ecosystem of the gut. The question is, are they friend, or are they foe? We have evaluated hundreds

The post Helminths as a Cause or a Potential Treatment for Autism? appeared first on Autism Research Institute.

]]>

Work in our laboratory has focused on immune function in the gut for more than a decade. Recently, our attention has turned to helminths, intestinal worms, which appear to be extremely important in the ecosystem of the gut. The question is, are they friend, or are they foe? We have evaluated hundreds of cases of individuals self-treating with helminths [1], which has provided us with some insight into this question.

During the course of our study of helminths and disease in Western society, we have recently encountered the view that some children with autism are infected with a large number of intestinal worms, called helminths.

Parents observe that removal of some of the apparent helminths can alleviate some of the symptoms of autism in some cases, at least temporarily. This has led some parents to conclude that helminths are a causative agent in the pathogenesis of autism, and that extreme measures should be taken to remove them. In support of this view, uncontrolled exposure to helminths in developing countries, often accompanied by malnutrition and dehydration, is associated with developmental delays. On the other hand, several scientists have predicted that controlled exposure to certain helminths in Western society might actually prevent or treat neuropsychiatric disorders, potentially including autism [2-5]. Thus, it is predicted that exposure to helminths in Western society will have a much different effect than uncontrolled exposure to helminths accompanied by malnutrition and dehydration in developing countries. A substantial body of scientific evidence supports those predictions [2, 6, 7].

The idea might be put forth that both good helminths and bad helminths exist, the good ones helping to treat autism and the bad ones making it worse. Although this idea would explain the conundrum, there exists another explanation which is much more consistent with the known facts.

The apparent helminths seen in autistic children are often observed following exposure to chlorine dioxide, a powerful oxidant. Use of broad spectrum toxins such as this will result in destruction of the lining of the gut and can result in an actual shedding of the gut lining. Very close examination of this shed material reveals a stringy, somewhat cloudy, mucus-like substance. We can be very confident that this material is not a helminth. It’s not even related to a helminth. However, just as a decaying leaf can be mistaken for a leech by a person who has never closely examined a leech, so might people who have never examined helminths be tricked by shed mucosal lining. When a sample is sent to a lab, laboratory personnel look for helminth eggs and often for any other physical signs that might indicate the presence of a helminth. My laboratory has frequently examined feces over the past 20 years, and any technician after only cursory training with a microscope can easily distinguish between the various components we find: bacteria; fiber particles from food; mucus; cells shed from the host; helminth eggs. Here is how we know that the material expelled following treatment with chlorine dioxide is NOT a helminth:

  1. The material shed from these children doesn’t look anything like a helminth to people who are accustomed to looking at helminths. Mother Nature has produced a vast array of helminths as well as other worms, such as liver flukes, that can colonize mammals. After years of examining the biome in wild animals, my lab has seen numerous sorts of flatworms and roundworms, and hundreds of examples. We have seen roundworms (nematodes) as small as 3/16 of an inch and flatworms (cestodes in particular) three feet long. Looking at a worm to an experienced biologist is much like looking at a car to the average Westerner. There may be hundreds of different shapes and sizes, but once we know what we are looking for, they are all very, very easy to spot. The material shed from these children lacks the fine structure and the detailed morphology that is easily recognized as a worm by experienced biologists.
  2. Severe diarrheal illnesses that have a known microbial cause can result in the shedding and excretion of wispy, stringy material. Since the cause can be firmly established as a bacterium, not a helminth, and since we can see under the microscope that the wispy, stringy material is not bacterial, we can be certain that the wispy, stringy material is of human origin. (Laboratory tests confirm this deduction.)
  3. Helminths make eggs. LOTS of eggs. That is what they do for a living. Each helminth currently in my laboratory makes almost 1500 eggs a day, which beats even the best chicken by a wide margin. The eggs of each helminth are fairly distinctive, just as a chicken egg is different from a blue jay egg. Nevertheless, all helminth eggs are easy to identify in the stool, just as bird eggs lying around in a chicken coop are easily recognizable. If there are no eggs, then there are no worms. It is true that many helminths (e.g., Hymenolepis nana and Taenia solium) can “hide” in the host without producing eggs, but when they are hiding, they are not in their adult (worm) form and they do not generally live in the lumen of the gut (with the food being digested) during that time.
  4. The material shed from children treated with chlorine dioxide looks like the gut lining under a microscope. The appearance of a gut lining is very distinctive under the microscope, as can be seen in our published work [8].
  5. We know that controlled exposure to helminths generally protects humans from inflammation and can be used to treat chronic inflammatory disease [2, 6, 7]. We also know that a very wide range of helminths seem to work [9]. Helminths have certain properties that allow them to live in the host, and those same properties help the host regulate its immune response; helminths and immune regulation go hand-in-hand [10]. Thus, we don’t expect to see good and bad helminths, some alleviating autism while others make it worse. In addition, our recently published survey of individuals self-treating with helminths can be considered. Some of the individuals we evaluated in that study have autism, and the available responses/reports indicate that helminth-mediated decreases in inflammation are helpful, not harmful to many individuals with autism [1]. Since that original paper was published, we have found additional information in the public domain, corroborated by interview with a physician, that helminths do indeed show a beneficial effect in patients with autism, particularly those with ongoing inflammatory issues. Specifically, the “average” response to the porcine whipworm (TSO), as described by the physician, of about 70 individuals with inflammation-associated autism (autism with gastrointestinal or allergic/autoimmune issues) was as follows:
    • Improvement of gastrointestinal issues, including diarrhea, abdominal bloating, abdominal pain, appetite, yeast, and dysbacteriosis.
    • Improvement in behavior linked to gut inflammation, including sleeping disturbances, grinding, self-injurious behaviors, aggressiveness, stereotypy, and hyperactivity.
    • Improvement of allergic symptoms, specifically asthma, rhinitis, and conjunctivitis.
    • Improvement of neuropsychiatric issues, including attention, focus, stable mood, OCD behaviors, receptive language, and learning.

    A number of factors, including potential side effects, can be evaluated when considering the use of helminths [1]. For example, the preparation of TSO used by those approximately 70 individuals with autism had a very low pH (2.7), a factor that is potentially important for the effectiveness of that organism [1]. As another example, two out of the approximately 70 individuals discontinued use of TSO due to “significant hyperactivity.” However, clearly, as described by the physician, the typical effect of helminths on patients with inflammation-associated autism was very positive.

    In addition, ongoing experimental work in my laboratory in collaboration with Professor Staci Bilbo has uncovered some of the underlying mechanisms of helminth-mediated protection of the brain from inflammation in laboratory animals (data not yet published). Although modern medical science cannot currently recommend helminths for the treatment of any disease, the emerging data are promising, and studies are underway which should eventually help us make recommendations.

  1. The argument can be made: “If I get these things out of my child, and my child is better, then these things must be bad. They must be something foreign, not my child’s own intestinal lining.” Although this argument makes sense on the surface, it has a fatal flaw. Because of the well-established gut-brain connection, and because of problems many children with autism have with their gut, it is entirely plausible that removing the gut epithelium might temporarily relieve some symptoms of autism in some cases. Indeed, the use of antibiotics which kill beneficial bacteria can temporarily relieve some neuropsychological symptoms in some children with autism [11], providing support for this view. Thus, a perfectly logical and reasonable explanation exists which encompasses all of the observations made by parents following use of chlorine dioxide, and it does not involve helminths. In contrast, as noted in the first five points above, any explanation involving helminths is contradicted by well-known information about the basic biology of helminths as well as other observations.

It is important for parents to know that treatment of their children with strong oxidants could damage their child’s gut lining. The view that they are simply hurting invasive and damaging worms is clearly not correct. As clinicians have pointed out see: Warning Against Chlorine Dioxide Use, this sort of destruction of the natural gut ecosystem is probably not a good long-term solution for treatment of disease, and it may have undesirable long-term consequences, making a bad situation worse.

By William Parker, Ph.D.
Duke University Medical Center, Durham, NC

References

  1. Cheng, A.M., et al., Overcoming evolutionary mismatch by self-treatment with helminths: current practices and experience. Journal of Evolutionary Medicine, 2015. 3: p. Article ID 235910.
  2. Parker, W. and J. Ollerton, Evolutionary biology and anthropology suggest biome reconstitution as a necessary approach toward dealing with immune disorders. Evolution, Medicine, and Public Health, 2013. 2013: p. 89–103.
  3. Rook, G.A.W. and C.A. Lowry, The hygiene hypothesis and affective and anxiety disorders, in Hygiene Hypothesis and Darwinian Medicine. 2009, Birkhauser Verlag Ag: Viadukstrasse 40-44, Po Box 133, Ch-4010 Basel, Switzerland. p. 189-220.
  4. Becker, K.G., Autism, asthma, inflammation, and the hygiene hypothesis. Medical Hypotheses, 2007. 69(4): p. 731-740.
  5. Raison, C.L., C.A. Lowry, and G.W. Rook, Inflammation, sanitation, and consternation: Loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Archives of General Psychiatry, 2010. 67(12): p. 1211-1224.
  6. Bilbo, S.D., et al., Reconstitution of the human biome as the most reasonable solution for epidemics of allergic and autoimmune diseases. Medical Hypotheses, 2011. 77(4): p. 494-504.
  7. Parker, W., et al., A prescription for clinical immunology: the pills are available and ready for testing. Current Medical Research and Opinion, 2012. 28: p. 1193-1202.
  8. Kotze, S.H., et al., Spontaneous bacterial cell lysis and biofilm formation in the colon of the Cape Dune mole-rat and the laboratory rabbit. Appl Microbiol Biotechnol, 2011. 90(5): p. 1773-83.
  9. Correale, J. and M. Farez, Association between parasite infection and immune responses in multiple sclerosis. Annals of Neurology, 2007. 61(2): p. 97-108.
  10. Hewitson, J.P., J.R. Grainger, and R.M. Maizels, Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Molecular & Biochemical Parasitology, 2009. 167(1): p. 1-11.
  11. Sandler, R.H., et al., Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol, 2000. 15(7): p. 429-35.

The post Helminths as a Cause or a Potential Treatment for Autism? appeared first on Autism Research Institute.

]]>